These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3615750

  • 21. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA, Szczepanik AM.
    Brain Res; 1989 May 22; 487(2):288-98. PubMed ID: 2525063
    [Abstract] [Full Text] [Related]

  • 22. Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary.
    Jaber M, Tison F, Fournier MC, Bloch B.
    Brain Res Mol Brain Res; 1994 Apr 22; 23(1-2):14-20. PubMed ID: 7518029
    [Abstract] [Full Text] [Related]

  • 23. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA, Masotto C, Ongini E, Racagni G.
    Eur J Pharmacol; 1985 Jun 07; 112(2):187-93. PubMed ID: 2863153
    [Abstract] [Full Text] [Related]

  • 24. Adenohypophysial dopamine content and prolactin secretion in the aged male and female rat.
    Demarest KT, Moore KE, Riegle GD.
    Endocrinology; 1985 Apr 07; 116(4):1316-23. PubMed ID: 3971917
    [Abstract] [Full Text] [Related]

  • 25. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E, Bohmaker K, Goldstein M, Schweitzer JW, Friedhoff AJ.
    Eur J Pharmacol; 1985 Mar 12; 109(3):389-94. PubMed ID: 3157587
    [Abstract] [Full Text] [Related]

  • 26. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW, Schwartz R, Friedhoff AJ.
    Res Commun Chem Pathol Pharmacol; 1982 Oct 12; 38(1):21-30. PubMed ID: 7146618
    [Abstract] [Full Text] [Related]

  • 27. Tumors producing chronic hyperprolactinemia do not alter [3H]spiperone binding and dopamine turnover in the corpus striatum of the female rat.
    Cronin MJ, Reches A, MacLeod RM, Login IS.
    Eur J Pharmacol; 1983 Jul 22; 91(2-3):229-34. PubMed ID: 6617744
    [Abstract] [Full Text] [Related]

  • 28. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
    Rupniak NM, Hall MD, Mann S, Fleminger S, Kilpatrick G, Jenner P, Marsden CD.
    Biochem Pharmacol; 1985 Aug 01; 34(15):2755-63. PubMed ID: 4040370
    [Abstract] [Full Text] [Related]

  • 29. Dissimilar effects of subchronic clozapine and haloperidol on operant lever pressing in C57BL/6J, BALB/cJ, and LP/J mice.
    McKerchar TL, Fowler SC.
    Behav Pharmacol; 2005 Nov 01; 16(7):585-9. PubMed ID: 16170236
    [Abstract] [Full Text] [Related]

  • 30. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1984 Nov 01; 84(4):512-9. PubMed ID: 6441952
    [Abstract] [Full Text] [Related]

  • 31. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
    Van der Krogt JA, Van Valkenburg CF, Belfroid RD, Heerkens CB.
    Eur J Pharmacol; 1988 Dec 06; 158(1-2):29-35. PubMed ID: 3220118
    [Abstract] [Full Text] [Related]

  • 32. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.
    Tecott LH, Kwong LL, Uhr S, Peroutka SJ.
    Biol Psychiatry; 1986 Oct 06; 21(12):1114-22. PubMed ID: 2428411
    [Abstract] [Full Text] [Related]

  • 33. Prenatal haloperidol alters striatal dopamine and opiate receptors.
    Moon SL.
    Brain Res; 1984 Dec 03; 323(1):109-13. PubMed ID: 6098328
    [Abstract] [Full Text] [Related]

  • 34. Hyperprolactinaemia does not alter specific striatal 3H-spiperone binding in the rat.
    Simpson MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1986 Oct 01; 35(19):3203-8. PubMed ID: 3768017
    [Abstract] [Full Text] [Related]

  • 35. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE.
    Brain Res; 1982 Jan 28; 232(2):401-12. PubMed ID: 6322915
    [Abstract] [Full Text] [Related]

  • 36. Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
    Koller WC.
    J Clin Psychopharmacol; 1984 Dec 28; 4(6):343-5. PubMed ID: 6512004
    [Abstract] [Full Text] [Related]

  • 37. On the mechanism by which dopamine inhibits prolactin release in the anterior pituitary.
    Pokras R, Tabakoff B.
    Life Sci; 1982 Dec 06; 31(23):2587-93. PubMed ID: 7154854
    [Abstract] [Full Text] [Related]

  • 38. Aging and the regulation of striatal dopaminergic mechanisms in mice.
    Randall PK, Severson JA, Finch CE.
    J Pharmacol Exp Ther; 1981 Dec 06; 219(3):695-700. PubMed ID: 7197719
    [Abstract] [Full Text] [Related]

  • 39. [The participation of the dopaminergic system of the striatum in the regulation of catalepsy in mice and rats of different genotypes].
    Skrinskaia IuA, Popova NK, Nikulina EM, Kulikov AV.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1997 Dec 06; 47(6):1032-9. PubMed ID: 9472169
    [Abstract] [Full Text] [Related]

  • 40. Aging and haloperidol-induced dopamine turnover in the nigro-striatal pathway of C57BL/6J mice.
    Severson JA, Osterburg HH, Finch CE.
    Neurobiol Aging; 1981 Dec 06; 2(3):193-7. PubMed ID: 7312097
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.